The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://twitter.com/telcosystems/status/1620685890484899842?s=61&t=lnhPSXxKfArOz924vkYfxw
Pretty state of the art solutions. Lanner hardware , Edgility OS allowing CVEDIA advanced recognition solutions to be empowered. Investors have eyes wired shut LOL
https://www.telco.com/lanner-electronics-telco-systems-and-cvedia-partner-to-showcase-the-power-of-edge-computing-with-computer-vision-ai-on-a-compact-edge-device-for-next-gen-retail-solutions/
This essentially is the guts required for autonomous vehicles plus endless other AI solutions.
The 25M for this order should not be confused with the 25M expected for the diagnostics division which has been awarded but not signed. Hopefully this will get signed off in the near future. Just thought I would mention this as they are both for the same $25M amount. Nice to see the new CEP pledge to increase their efforts to market the very substantial IP they have.
BATM and Celare have several cyber offerings. This win is in the Government sector. The company hope to use this successful format to offer to corporate clients. BATM also are starting to see the first revenues from Edgility which itself has cyber bundled with it which is another area of revenue which should accelerate in the near term. BATM do have the intention to sell off this part of the business in @ 2 years. They will retain other cyber initiatives. BATM cyber arm is probably worth half the current market cap for BATM at these depressed levels. Interesting times and new CEO in place.
Shares were sold off for a variety of unrelated issues all of which did not reflect the progress the company was making on developing and marketing its IP with no dilution to shareholders. Perfect storm of events from misinformation to a sell off in the diagnostics sector, getting dropped from indexes. They are severely undervalued.
I agree they severely underestimated the damage getting ejected from the index caused. It’s still not sorted so IMO. they should face reality and drop the TASE listing The dual listing causes more problems than the device it provides.
In what has been an incredibly difficult year for the markets this is very encouraging. Remember companies are yet to report FY 2022 and when they do it’s going to be a bad scene. Positive take outs are that Edgility non covid sales cyber all gaining traction and headed in the right direction. This a welcome update.
It’s all coming together. They should be able to get a good slice of the market and for a company of this size it will be hard to ignore.
The medical division should be busy with identifying the recent spate of pathogens. Ador have a lower respiratory panel in operation
Revenue from Edgility will come from a variety of sources everything from Providers to Large Corporation infrastructure adoptions. It is a cumulative revenue which repeats and adds new clients. Initial revenue may not look like much but the potential to grow to a very significant amount will increase as we go forwards. There are bolt ons with the edgily suite including cyber solutions etc
Heres a direct link to Edgility. Just cut and paste to Google
edgilityos.com/
Cagney you missed the 10:1 share split still its bad enough. The current SP makes no sense at all. Outside of the fact that BATM have plenty of cash and are profitable. They also have 2 market disrupters that are being introduced to the market having cleared POC's etc. I refer to ADOR Diagnostics RCA platform and Telco systems Edgility. Of course the company has an excellent cyber division Celare that handles Government Military contracts and is being redesigned and offered to commercial clients which is a high growth area. The SP plummeted when markets thought this was a pure covid play which it is certainly NOT. The company and their advisors messed up the Russell Index listing and someone wrote a false report about the company to support a short position. Company is worth >120p but in this environment and with the attempts to drive the price down we are where we are at.
They are absurdly undervalued.
Markets totally ignored this announcement back in March 22nd 2022.
City Fibre is one of numerous revenue streams for Telco Systems which is actually a US company based in Foxborough Mass albeit it owned by BATM
www.telco.com/telco-systems-and-nexcom/
Its worth looking at ADOR website which has been updated.
http://www.adordx.com
ADOR are with Adaltis at Medica Nov 14th to 17th.
New diagnostics platform employing RCA. Rolling Circle Amplification is close to market.
Now is not the time to sell IMO
BATM got clobbered on the misconception it was a Covid Company so when the demand for tests fell away then the company SP got slammed. Less obvious is the fact that the Bio Med non covid business grew where by the end of this year it will have made up for the Covid tests losses. BATM actually saw growth in the first half of 2022 in all divisions and they made a profit. >nutmeg.. if you know how this was done we are all ears. It is massively oversold and completely miscategorised.
Volumes were high on TASE and LSE. Weakness has started on TASE for months now and then got walked down on LSE with very low volumes and no one wanting to catch the proverbial falling knife. BATM is well funded, profitable with some soon to be exploited valuable IP. FMV for BATM likely around the 80p mark so they have a lot of daylight above them.
Its true that Edgility revenue will start as a trickle which its already doing. As the use of Edge computing and virtual networks expands Telco Systems gain from new clients but they should retain a large part of existing clients so its a cumulative revenue flow. Company has plenty of cash in the bank, makes a profit and pays for the development of its IP in house with no dilution to shareholders. When assessing what BATM actually makes yearly if you add the existing profit to their R&D costs it makes a large difference when comparing many companies who do not have large R&D budgets.
BATM partners with CityFibre for Edgility
The UK's largest independent carrier-neutral Full Fibre platform selects the Group's virtual network and edge compute solution
BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that CityFibre, the UK's largest independent carrier-neutral Full Fibre platform, has selected BATM's Edgility virtual networking and edge compute solution. Following extensive lab testing, CityFibre will now be piloting the Edgility platform with selected partners ahead of an expected national deployment to provide virtualised network services for businesses.